BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 1704008)

  • 1. The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.
    Morgan L; Jessen KR; Mirsky R
    J Cell Biol; 1991 Feb; 112(3):457-67. PubMed ID: 1704008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
    Mews M; Meyer M
    Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of the P0 gene in Schwann cells: suppression of P0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGF beta 1, TGF beta 2 and TGF beta 3.
    Morgan L; Jessen KR; Mirsky R
    Development; 1994 Jun; 120(6):1399-409. PubMed ID: 7519543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta 1 regulates axon/Schwann cell interactions.
    Einheber S; Hannocks MJ; Metz CN; Rifkin DB; Salzer JL
    J Cell Biol; 1995 Apr; 129(2):443-58. PubMed ID: 7536747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary demyelination induced by exposure to tellurium alters Schwann cell gene expression: a model for intracellular targeting of NGF receptor.
    Toews AD; Griffiths IR; Kyriakides E; Goodrum JF; Eckermann CE; Morell P; Thomson CE
    J Neurosci; 1992 Sep; 12(9):3676-87. PubMed ID: 1382124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P0 gene expression in Schwann cells is modulated by an increase of cAMP which is dependent on the presence of axons.
    LeBlanc AC; Windebank AJ; Poduslo JF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):31-8. PubMed ID: 1372071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3',5'-monophosphate.
    Mokuno K; Sobue G; Reddy UR; Wurzer J; Kreider B; Hotta H; Baron P; Ross AH; Pleasure D
    J Neurosci Res; 1988; 21(2-4):465-72. PubMed ID: 2851058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The second messenger, cyclic AMP, is not sufficient for myelin gene induction in the peripheral nervous system.
    Poduslo JF; Walikonis RS; Domec MC; Berg CT; Holtz-Heppelmann CJ
    J Neurochem; 1995 Jul; 65(1):149-59. PubMed ID: 7540661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue culture studies of Schwann cell proliferation and differentiation.
    Pleasure D; Kreider B; Shuman S; Sobue G
    Dev Neurosci; 1985; 7(5-6):364-73. PubMed ID: 2424706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in DNA synthesis rate in the Schwann cell lineage in vivo are correlated with the precursor--Schwann cell transition and myelination.
    Stewart HJ; Morgan L; Jessen KR; Mirsky R
    Eur J Neurosci; 1993 Sep; 5(9):1136-44. PubMed ID: 7506619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro.
    Lisak RP; Bealmear B; Benjamins J; Skoff A
    Neurology; 1998 Dec; 51(6):1661-5. PubMed ID: 9855519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes.
    Lemke G; Chao M
    Development; 1988 Mar; 102(3):499-504. PubMed ID: 2846259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schwann cell precursors and their development.
    Jessen KR; Mirsky R
    Glia; 1991; 4(2):185-94. PubMed ID: 1851727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that secondary rat Schwann cells in culture maintain their differentiated phenotype.
    Rutkowski L; Needham L; Frayer K; Carson D; McKhann G; Tennekoon GI
    J Neurochem; 1990 Jun; 54(6):1895-904. PubMed ID: 1692582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 and forskolin modulate gap junctional communication and cellular phenotype of cultured Schwann cells.
    Chandross KJ; Chanson M; Spray DC; Kessler JA
    J Neurosci; 1995 Jan; 15(1 Pt 1):262-73. PubMed ID: 7823132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
    Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
    J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmyelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3 antigen and glial fibrillary acidic protein.
    Jessen KR; Mirsky R
    J Neurocytol; 1984 Dec; 13(6):923-34. PubMed ID: 6398831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclic AMP analogue induces synthesis of a myelin-specific glycoprotein by cultured Schwann cells.
    Shuman S; Hardy M; Sobue G; Pleasure D
    J Neurochem; 1988 Jan; 50(1):190-4. PubMed ID: 2447234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation-specific regulation of Schwann cell expression of the major myelin glycoprotein.
    Poduslo JF; Windebank AJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5987-91. PubMed ID: 2412226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of responses to nerve growth factor and of microtubule-associated protein phosphorylation by activators of adenylate cyclase.
    Greene LA; Drexler SA; Connolly JL; Rukenstein A; Green SH
    J Cell Biol; 1986 Nov; 103(5):1967-78. PubMed ID: 3023392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.